Networking +
Policy +
Member
Career
Choose
Weekly Policy Update: President Biden Signs New Drug Pricing Executive Order
By: Colorado BioScience Association Date: 10/21/2022
President Biden signed an Executive Order on Friday, October 14th directing Health and Human Services (HHS) to explore additional actions to lower prescription drug costs. This order is on top of...
Learn MoreWeekly Policy Blog: CBSA Engages on Transitional Coverage for Emerging Technologies (TCET)
By: Colorado BioScience Association Date: 10/14/2022
The Centers for Medicare & Medicaid Services (CMS) are currently working to develop a new rule that could provide Medicare patients faster access to innovative, lifesaving, and life-enhancing medi...
Learn MoreWeekly Policy Blog: CBSA Continues Engagement on the WTO TRIPS Waiver
By: Colorado BioScience Association Date: 10/07/2022
In a few months, member states of the World Trade Organization (WTO) will decide whether to expand the TRIPS waiver to include COVID-19 therapeutics and diagnostics. Colorado BioScience Association is...
Learn MoreVictories for Innovation: Congress Reauthorizes the SBIR/STTR and User Fee Programs
By: Colorado BioScience Association Date: 09/30/2022
CBSA celebrates policy victories for Colorado's life sciences community and America’s innovators, scientists, and entrepreneurs. Congress reauthorized critical SBIR/STTR and User Fee programs. Without...
Learn MoreWeekly Update: Biden Administration Cancer Moonshot Initiative; Bi-Partisan Majority Support in Congress - Multi-Cancer Early Detection Screening Coverage Act (S.1873/ H.R. 1946)
By: Colorado BioScience Association Date: 09/23/2022
President Biden’s Cancer Moonshot Initiative On the 60th anniversary of President Kennedy’s “We Choose to Go to the Moon” speech, President Biden gave an update on his Cancer Moonshot Initiative, whic...
Learn MoreWeekly Policy Blog: Colorado BioScience Political Action Committee Fuels Policy + Advocacy Engagement and Impact
By: Colorado BioScience Association Date: 09/09/2022
The Colorado BioScience Political Action Committee (CBSA PAC), a bipartisan state political action committee, provides opportunities to educate candidates for the state legislature about our life scie...
Learn MoreWeekly Policy Blog: August Prescription Drug Affordability Review Board (PDAB) Meeting
By: Colorado BioScience Association Date: 09/02/2022
On August 26, CBSA and our partners participated in the state Prescription Drug Affordability Review Board (PDAB) meeting, which was open to the public. The PDAB was created in 2021 when the state leg...
Learn MoreWeekly Policy Blog: Ethylene Oxide – Critical in Protecting Patient Health
By: Colorado BioScience Association Date: 08/26/2022
Ethylene Oxide (EtO or EO) is a colorless gas used commercially in a wide variety of ways, including the production of textiles, personal care items, and the sterilization of medical devices, cosmetic...
Learn MoreWeekly Policy Blog: President Biden Signs Inflation Reduction Act into Law
By: Colorado BioScience Association Date: 08/17/2022
On August 16, 2022, President Biden signed the Inflation Reduction Act, a bill aimed at addressing high inflationary costs. The massive bill increases corporate taxes and includes measures designed to...
Learn MoreWeekly Policy Blog: Deadline Approaches to Reauthorize User Fee Agreements
By: Colorado BioScience Association Date: 08/12/2022
CBSA and our national partners support the renewal of the critically important User Fee Agreements, including the Pharmaceutical Drug User Fee Act (PDUFA) and the Medical Device User Fee Act (MDUFA)....
Learn More